Literature DB >> 177035

Treatment of transplanted rat tumours with double-stranded RNA (BRL 5907). I. Influenced of systemic and local administration.

M V Pimm, M J Embleton, R W Baldwin.   

Abstract

Growth of transplanted rat tumours was retarded and in some cases completely suppressed when cells were injected subcutaneously in admixture with double stranded RNA (ds-RNA). This response required intimate contact between ds-RNA and tumour cells and systemic treatment with the agent failed to prevent progressive growth of a range of rat tumours. Direct cytotoxic effects of ds-RNA may contribute to tumour suppression since the compound was cytotoxic in vitro for cultured tumour cells. The involvement of host factors is suggested, however, by the in vivo tests showing variations in susceptibility to ds-RNA mediated tumour suppression similar to that previously observed with bacterial adjuvants.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177035      PMCID: PMC2024938          DOI: 10.1038/bjc.1976.20

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  BCG therapy of pleural and peritoneal growth of transplanted rat tumours.

Authors:  M V Pimm; R W Baldwin
Journal:  Int J Cancer       Date:  1975-02-15       Impact factor: 7.396

2.  The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors.

Authors:  J C Fisher; S R Cooperband; J A Mannick
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

3.  Inhibition of polyoma-virus oncogenesis in rats by polyriboinosinic-ribocytidylic acid.

Authors:  M Vandeputte; S K Datta; A Billiau; P De Somer
Journal:  Eur J Cancer       Date:  1970-08       Impact factor: 9.162

4.  Influence of synthetic double-stranded ribonucleic acid (poly I:C) on SV40 viral oncogenesis and transplant tumor in hamsters.

Authors:  V M Larson; P N Panteleakis; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

5.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

6.  Neoantigens on spontaneous and carcinogen-induced rat tumors defined by in vitro lymphocytotoxicity assays.

Authors:  R W Baldwin; M J Embleton
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

7.  Methanol extraction residue of BCG in the treatment of transplanted rat tumours.

Authors:  D G Hopper; M V Pimm; R W Baldwin
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

8.  Treatment of transplanted rat tumours with double-stranded RNA(BRL 5907). II. Treatment of pleural and peritoneal growths.

Authors:  M V Pimm; R W Baldwin
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

9.  B.C.G. suppression of pulmonary metastases from primary rat hepatomata.

Authors:  R W Baldwin; M V Pimm
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

10.  Immunogenic properties of rat hepatoma subcellular fractions.

Authors:  M R Price; R W Baldwin
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

View more
  1 in total

1.  Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity.

Authors:  Uyen M Le; Darryl G L Kaurin; Brian R Sloat; Nijaporn Yanasarn; Zhengrong Cui
Journal:  Radiother Oncol       Date:  2008-11-14       Impact factor: 6.280

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.